Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00228 Intradialytic Parenteral Nutrition-Retired PolicyPayerPolicy · BCBSLA-00228-4C43CF7AEC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00311 Intracellular Micronutrient Analysis - Retired PolicyPayerPolicy · BCBSLA-00311-2AF7D53579 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00434 Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain-Retired PolicyPayerPolicy · BCBSLA-00434-74BA43E9F6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00076 Intra-arterial Brachytherapy for the Management and Treatment of Restenosis after Percutaneous Transluminal Angioplasty (PTA) -Retired PolicyPayerPolicy · BCBSLA-00076-B2F4349351 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00221 Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)PayerPolicy · BCBSLA-00221-F5DF15B7D8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00212 Interferon gamma-1B (Actimmune)PayerPolicy · BCBSLA-00212-6C91055B02 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00453 interferon beta 1-b (Betaseron)-Retired PolicyPayerPolicy · BCBSLA-00453-272479E69B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00167 Intense Pulsed Light Therapy--retiredPayerPolicy · BCBSLA-00167-8EDB79D07F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00395 Insulins (Non-Long Acting Products)PayerPolicy · BCBSLA-00395-BE6B320637 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00545 insulin glargine (Basaglar)- Retired PolicyPayerPolicy · BCBSLA-00545-634BBBDE06 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00487 insulin degludec (Tresiba)-retired policyPayerPolicy · BCBSLA-00487-F0DFE8CE07 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00074 Inpatient Intestinal Rehabilitation Therapy - Retired PolicyPayerPolicy · BCBSLA-00074-89A4B27A21 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00256 Injectable Clostridial Collagenase for Fibroproliferative DisordersPayerPolicy · BCBSLA-00256-980870CC30 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00095 Injectable Bulking Agents for the Treatment of Urinary and Fecal IncontinencePayerPolicy · BCBSLA-00095-56BF48F845 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00519 Inhaled Antibiotics for Cystic Fibrosis (tobramycin, Tobi, Tobi Podhaler, Bethkis, Cayston)PayerPolicy · BCBSLA-00519-1457B6F31A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00470 Wireless Capsule for the Evaluation of Suspected Gastric and Intestinal Motility DisordersPayerPolicy · BCBSLA-00470-CA5BF713C2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00539 infliximab-dyyb (Inflectra)-Retired PolicyPayerPolicy · BCBSLA-00539-0B603F2F81 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00164 Implantation of Intrastromal Corneal Ring Segments-Retired PolicyPayerPolicy · BCBSLA-00164-BFEF90BD86 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00073 Implantable Hormone PelletsPayerPolicy · BCBSLA-00073-8275284EE7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00004 Implantable Bone-Conduction and Bone-Anchored Hearing AidsPayerPolicy · BCBSLA-00004-83ADCFAD50 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00177 Immune Prophylaxis for Respiratory Syncytial VirusPayerPolicy · BCBSLA-00177-9CAE0610A1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00278 Image-Guided Minimally Invasive Decompression for Spinal StenosisPayerPolicy · BCBSLA-00278-F33B336299 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00072 Hysteroscopic Placement of Micro-inserts in the Fallopian Tubes as a Form of Permanent Sterilization - Retired PolicyPayerPolicy · BCBSLA-00072-5665DA25FB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00070 Hyperbaric Oxygen Therapy (HBO)PayerPolicy · BCBSLA-00070-82B10304CB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00302 hydroxyprogesterone caproate Injection (Makena, generics)-Retired PolicyPayerPolicy · BCBSLA-00302-A2D514D18F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00188 Human Growth HormonePayerPolicy · BCBSLA-00188-EA3DC67AB8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00068 Home Uterine Activity MonitoringPayerPolicy · BCBSLA-00068-9955176D69 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00224 Home Prothrombin Time Monitoring-Retired PolicyPayerPolicy · BCBSLA-00224-442ED94A0C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00102 Home Phototherapy for Neonatal Jaundice - Retired PolicyPayerPolicy · BCBSLA-00102-CC8F8646F3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00339 HMG-CoA Reductase Inhibitors and HMG-CoA Reductase Inhibitor Combination DrugsPayerPolicy · BCBSLA-00339-BA1A412B29 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00067 HIV Genotyping and Phenotyping- Retired PolicyPayerPolicy · BCBSLA-00067-9439171CF0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00119 Hip ResurfacingPayerPolicy · BCBSLA-00119-2D411841A2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00066 Hippotherapy-Retired PolicyPayerPolicy · BCBSLA-00066-1BA2F5FEFA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00056 Hematopoietic Cell Transplantation in the Treatment of Germ-Cell TumorsPayerPolicy · BCBSLA-00056-CEFEB99615 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00064 Hematopoietic Cell Transplantation for Solid Tumors of ChildhoodPayerPolicy · BCBSLA-00064-E91BBDD0D3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00138 Hematopoietic Cell Transplantation for Primary Amyloidosis or Waldenstrom’s MacroglobulinemiaPayerPolicy · BCBSLA-00138-88597DDB70 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00062 Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasPayerPolicy · BCBSLA-00062-BC402D4916 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00059 Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · BCBSLA-00059-67553FBBCA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00057 Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · BCBSLA-00057-B81A68E922 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00054 Hematopoietic Cell Transplantation for Epithelial Ovarian CancerPayerPolicy · BCBSLA-00054-A749DE4F92 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00053 Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaPayerPolicy · BCBSLA-00053-993C863261 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00052 Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaPayerPolicy · BCBSLA-00052-5AB31CD516 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00051 Hematopoietic Stem Cell Transplantation for Breast Cancer-Retired PolicyPayerPolicy · BCBSLA-00051-BB5558EDB0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00050 Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · BCBSLA-00050-718D821773 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00049 Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · BCBSLA-00049-E5FD2BCEAA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00048 Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · BCBSLA-00048-A963E2E951 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00063 Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and EpendymomaPayerPolicy · BCBSLA-00063-58FF5AF651 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00223 golimumab (Simponi Aria, Simponi)PayerPolicy · BCBSLA-00223-F6CA7A9940 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00324 GLP-1, GIP/GLP-1 Agonists for DiabetesPayerPolicy · BCBSLA-00324-6FC91B9DC7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00299 Genotyping for 9p21 Single Nucleotide Polymorphisms to Predict Risk of Cardiovascular Disease or Aneurysm - Retired PolicyPayerPolicy · BCBSLA-00299-AEC9785DCF | New policy |
|---|